Unlock instant, AI-driven research and patent intelligence for your innovation.

Nucleic acid complex

A complex, nucleic acid technology, applied in the field of nucleic acid complexes, can solve problems such as limited scope of application

Active Publication Date: 2019-03-01
KYOWA HAKKO KIRIN CO LTD
View PDF24 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0016] The conventional nucleic acid complexes reported in Patent Documents 1 to 4 basically use the liver as the target organ, and their scope of application is limited

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nucleic acid complex
  • Nucleic acid complex
  • Nucleic acid complex

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0721] Synthesis of Embodiment 1 Linker Unit 1

[0722] Synthesis of compound 9

[0723] [chemical formula 115]

[0724]

[0725] Process 1

[0726] Dimethyl 5-hydroxyisophthalate (compound 1, manufactured by Wako Pure Chemical Industries, Ltd., 5.0443 g, 24 mmol) was dissolved in tetrahydrofuran (manufactured by Wako Pure Chemical Industries, Ltd., 25 mL), and 2-(tert-butoxycarbonyl Amino)-1-ethanol ((Tokyo Chemical Industry Co., Ltd., 4.0343g, 25.03mmol), and triphenylphosphine supported on the polymer (Aldrich Co., 6.61g, 25.2mmol), and then under ice cooling, add 40% diisopropyl azodicarboxylate (DIAD) toluene solution (manufactured by Tokyo Chemical Industry Co., Ltd., 13.26 mL, 25.2 mmol), stirred overnight at room temperature. The reaction solution was filtered, and the filtrate was distilled off under reduced pressure, and then The residue was purified by amino silica gel column chromatography (hexane / ethyl acetate=95 / 5 to 80 / 20) to obtain compound 2 (5.3071 g, y...

Embodiment 2

[0751] Synthesis 2 of embodiment 2 linker unit

[0752] Synthesis of Compound 19

[0753] [chemical formula 116]

[0754]

[0755] Process 9

[0756] Using Compound 2 (2.1 g, 5.940 mmol) synthesized in Step 1 of Example 1, Compound 10 was quantitatively obtained by the same method as in Step 4 of Example 1.

[0757] ESI-MS m / z: 254 (M+H) +

[0758] 1 H-NMR (DMSO-D6) δ: 3.26 (2H, t, J = 5.1 Hz), 3.90 (6H, s), 4.30 (2H, t, J = 5.1 Hz), 7.77 (2H, dd, J = 1.5 , 0.8Hz), 8.13 (1H, dd, J=1.4, 0.7Hz).

[0759] Process 10

[0760] Compound 10 (0.427 g, 1.686 mmol) synthesized in Step 9 and 6-azidohexanoic acid synthesized by the method described in Organic & Biomolecular Chemistry, Vol. 13, pp. 1778-1791, 2015 were used Pyrrolidinyl ester (0.6 g, 2.360 mmol), compound 11 (0.248 g, yield 38%) was obtained by the same method as in step 5 of Example 1.

[0761] ESI-MS m / z: 393 (M+H) +

[0762] 1 H-NMR (CDCl 3)δ: 1.37-1.44 (2H, m), 1.64-1.69 (4H, m), 2.23 (2H, t, J = 7.5Hz)...

Embodiment 3

[0795] Synthesis of embodiment 3 linker unit 3

[0796] Synthesis of compound 22

[0797] [chemical formula 117]

[0798]

[0799] Process 18

[0800] (a); Compound 13 (10 mg, 17.9 μmol) synthesized in the procedure 12 of Example 2 was dissolved in a mixed solution of tetrahydrofuran (90 μL) and phosphate buffer (90 μL), and carboxyl-(12 low ethylene glycol) was added Ethylamine (manufactured by Thermo Scientific, 22.1 mg, 35.8 μmol) was stirred at room temperature under an argon atmosphere for 1 h. The solvent was distilled off under reduced pressure, extracted with chloroform and 10% aqueous citric acid solution, and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to obtain a crude product of Compound 17.

[0801] ESI-MS m / z: 1564 (M+H) +

[0802] (b); Compound 13 (10 mg, 17.9 μmol) synthesized in the procedure 12 of Example 2 was dissolved in a mixed solution of tetrahydrofuran (90 μL) and phosphate buffer (90 μL), and c...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides a nucleic acid complex in which a sugar chain ligand is bonded to an oligonucleotide via a linker, wherein the sugar chain has an O-linked mannose at a non-reducing endthereof.

Description

technical field [0001] The present invention relates to a nucleic acid complex, a pharmaceutical composition containing the nucleic acid complex, and the like. Background technique [0002] Antisense nucleic acid, Decoy nucleic acid, ribozyme, siRNA, miRNA, antimiRNA, etc. are known as a nucleic acid drug. Due to their high versatility (capable of controlling all genes in cells), nucleic acid drugs are expected to be clinically applied to various diseases that are currently considered difficult to treat. [0003] In addition, nucleic acid drugs are highly anticipated as next-generation drugs after antibodies and low-molecular-weight drugs due to their high intracellular targeting selectivity and high activity. [0004] However, as a problem with nucleic acid drugs, it is difficult to deliver them to target tissues. [0005] As one of the effective delivery methods of nucleic acid drugs in vivo, the use of nucleic acid complexes (conjugate nucleic acids) of targeting compou...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07H21/02A61K31/7088A61K47/54A61K48/00C12N15/113C12N15/09
CPCC12N15/113C12N15/111C12N2310/14C12N2310/315C12N2310/3231C12N2310/11C12N2310/341C12N2320/32A61K47/549A61K47/61A61K47/60C07H21/04C12N2310/321C12N2310/3521C12N2310/322C12N2310/3533A61K47/54A61K31/7088C07H21/02C12N15/1138C12N2310/351C12N15/09A61K48/00A61K9/0019
Inventor 上原启嗣铃木康裕春元俊正岩井宏徒牧野麻奈
Owner KYOWA HAKKO KIRIN CO LTD